Viva 5 licenses NUtech Ventures’ probiotic for new synbiotic product

By Adi Menayang contact

- Last updated on GMT

iStock / frentusha
iStock / frentusha
Viva 5 will be the exclusive worldwide distributor of a new synbiotic ingredient—a combination of probiotic and prebiotic—after signing a licensing agreement with NUtech Ventures, the technology commercialization affiliate for the University of Nebraska-Lincoln.

The newly licensed, patent-pending probiotic is Bifidobacterium adolescentis ​IVS-1, isolated via a novel prebiotic enrichment strategy known as In Vivo Selection ​(hence the IVS). The synbiotic was formulated by researchers at University of Nebraska-Lincoln.

It is being commercialized by NUTech Ventures​, an intellectual property and commercialization unit of the university with a mission to facilitate the commercial and practical use of innovations generated through the university’s research activities.

The synbiotic is a combination of the Bifidobacterium adolescentis ​IVS-1 with a galactooligosaccharide prebiotic.

“Most, if not all, of the synbiotics on the market have not been rationally formulated based on ecological criteria. They have been combined based on cost, marketing, or limited or no scientific studies showing evidence for synergistic or additive effects,” ​said Albert Dahbour, executive vice president at Viva 5 Corporation​.

“In a true synbiotic, the prebiotic should have high affinity for the probiotic, it should selectively support growth of the probiotic in the human intestinal tract and, ultimately, show a health benefit to the host. Thus, Viva 5 now has in our opinion the first real synbiotic and we are looking to further invest in additional research.”

Viva 5 Corporation’s newly licensed synbiotic will be available in capsule, tablet, stick pack, and powder delivery forms and can be utilized as a stand-alone product or combined with other compatible ingredients.

Related news

Show more

Related products

show more

Innovative colic solutions

Innovative colic solutions

Recorded the 07-Jul-2022 | Webinar

Colic is one of the most frequent reasons for visits to the pediatrician and can often lead to parental and infant exhaustion. As a functional gastrointestinal...

Register for free



BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Jun-2022 | Technical / White Paper

The intake of 100 mg/day of the standardized Red Orange Complex extract containing anthocyanins, hydroxycinnamic acids, flavanones, and ascorbic acid is...

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 06-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Related suppliers

Follow us


View more